{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:41:37Z","timestamp":1792118497916,"version":"4.4.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","award":["EP\/M027341\/1"],"award-info":[{"award-number":["EP\/M027341\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cis.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T09:45:31Z","timestamp":1494755131000},"page":"100-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":569,"special_numbering":"C","title":["Formulation, stabilisation and encapsulation of bacteriophage for phage therapy"],"prefix":"10.1016","volume":"249","author":[{"given":"Danish J.","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya J.","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinder K.","family":"Vinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cinquerrui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran T.","family":"Vladisavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha R.J.","family":"Clokie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Garton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.F.","family":"Stapley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kirpichnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2017.05.014_bb0005","first-page":"1","article-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O\u2019Neill","year":"2016","journal-title":"Rev Antimicrob Resist"},{"key":"10.1016\/j.cis.2017.05.014_bb0010","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMp1011715","volume":"363","author":"Moellering","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cis.2017.05.014_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?","volume":"163","author":"Coates","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cis.2017.05.014_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics \u2014 a pipeline portfolio review","volume":"16","author":"Czaplewski","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/viru.25991","article-title":"A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens","volume":"5","author":"Wittebole","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.cis.2017.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aad6791","article-title":"Phage therapy redux \u2014 what is to be done?","volume":"350","author":"Young","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cis.2017.05.014_bb0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000253","article-title":"Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy","volume":"5","author":"Cairns","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cis.2017.05.014_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2014.00618","article-title":"The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages","volume":"5","author":"Bull","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/00221287-143-1-179","article-title":"bateriophage T4 development depends on the physiology of its host Escherichia coli","volume":"143","author":"Hadas","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.cis.2017.05.014_bb0060","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation and preparation for phage therapy","volume":"11","author":"Gill","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.cis.2017.05.014_bb0065","first-page":"1","article-title":"Bacteriophage procurement for therapeutic purposes","volume":"7","author":"Weber-Dabrowska","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy","volume":"6","author":"Mattila","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1097(04)00041-2","article-title":"The interaction of phage and biofilms","volume":"232","author":"Sutherland","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.cis.2017.05.014_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018597","article-title":"The t7-related pseudomonas putida phage \u03c615 displays virion-associated biofilm degradation properties","volume":"6","author":"Cornelissen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0085","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00253-015-7247-0","article-title":"Bacteriophage-encoded depolymerases: their diversity and biotechnological applications","volume":"100","author":"Pires","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.cis.2017.05.014_bb0090","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/AEM.03560-14","article-title":"Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono- and dual-species staphylococcal biofilms","volume":"81","author":"Guti\u00e9rrez","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0095","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis biofilms with phage therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0100","first-page":"1111","article-title":"The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages","volume":"133","author":"Smith","year":"1987","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3354\/dao037033","article-title":"Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail","volume":"37","author":"Nakai","year":"1999","journal-title":"Dis Aquat Organ"},{"key":"10.1016\/j.cis.2017.05.014_bb0110","first-page":"2659","article-title":"Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs","volume":"129","author":"Smith","year":"1983","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0115","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/AEM.00049-07","article-title":"Bacteriophage therapy to reduce Salmonella colonization of broiler chickens","volume":"73","author":"Atterbury","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0120","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00216-015-9087-2","article-title":"Application of bacteriophages in sensor development","volume":"408","author":"Peltomaa","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.cis.2017.05.014_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mib.2013.01.005","article-title":"Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection","volume":"16","author":"Ulett","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1086\/651135","article-title":"Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections","volume":"201","author":"Debarbieux","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00029-12","article-title":"Bacteriophage phiMR299-2 and phiNH-4 can eliminate Psuedomonas aeruginosa in the murine lung and on cystic fibrosis lung airway","volume":"3","author":"Alemayehu","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.cis.2017.05.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016963","article-title":"Pulmonary bacteriophage therapy on pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention","volume":"6","author":"Morello","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0145","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1099\/00221287-128-2-307","article-title":"Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics","volume":"128","author":"Smith","year":"1982","journal-title":"Microbiology"},{"key":"10.1016\/j.cis.2017.05.014_bb0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jiv029","article-title":"Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia","volume":"212","author":"Singla","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0160","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1099\/jmm.0.2008\/002873-0","article-title":"Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice","volume":"57","author":"Chhibber","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0165","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0170","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.01028-06","article-title":"Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model","volume":"51","author":"McVay","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cis.2017.05.014_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.cis.2017.05.014_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00013-11","article-title":"Polymicrobial interactions: impact on pathogenesis and human disease","volume":"25","author":"Peters","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jviromet.2016.07.002","article-title":"Phospholipid vesicles encapsulated bacteriophage: a novel approach to enhance phage biodistribution","volume":"236","author":"Singla","year":"2016","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cis.2017.05.014_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1381612820666140905112311","article-title":"Bacteriophage and their enzymes in biofilm control","volume":"21","author":"Chan","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cis.2017.05.014_bb0205","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1128\/AEM.01166-16","article-title":"Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis","volume":"82","author":"Furusawa","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/649227","article-title":"Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection","volume":"201","author":"Carmody","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00261-16","article-title":"Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae","volume":"1","author":"Martin","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.cis.2017.05.014_bb0220","series-title":"Global tuberculosis report","author":"WHO","year":"2016"},{"key":"10.1016\/j.cis.2017.05.014_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-resistant tuberculosis","volume":"9","author":"Jassal","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0230","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don't know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science (80- )"},{"key":"10.1016\/j.cis.2017.05.014_bb0235","first-page":"1","article-title":"A first step toward liposome-mediated intracellular bacteriophage therapy","author":"Nieth","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40362-014-0027-x","article-title":"A question of attire: dressing up bacteriophage therapy for the battle against antibiotic-resistant intracellular bacteria","volume":"3","author":"Nieth","year":"2015","journal-title":"Springer Sci Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0245","doi-asserted-by":"crossref","first-page":"e009283","DOI":"10.1136\/bmjopen-2015-009283","article-title":"Health economic burden that different wound types impose on the UK's National Health Service","volume":"5","author":"Guest","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.cis.2017.05.014_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/iwj.12623","article-title":"Wound management for the 21st century: combining effectiveness and efficiency","volume":"13","author":"Lindholm","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.cis.2017.05.014_bb0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1309\/LMBNSWKUI4JPN7SO","article-title":"Chronic wound biofilms: pathogenesis and potential therapies","volume":"46","author":"Clinton","year":"2015","journal-title":"Lab Med"},{"key":"10.1016\/j.cis.2017.05.014_bb0260","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1524-475X.2009.00536.x","article-title":"HaCaT keratinocytes in co-culture with Staphylococcus aureus can be protected from bacterial damage by polihexanide","volume":"17","author":"Wiegand","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.cis.2017.05.014_bb0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2005.01238.x","article-title":"Review. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance","volume":"11","author":"Peterson","year":"2005","journal-title":"Clin Microbiol Infect Suppl"},{"key":"10.1016\/j.cis.2017.05.014_bb0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0037263","article-title":"Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains","volume":"7","author":"Nale","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(03)00606-6","article-title":"Effect of washing hands with soap on diarrhoea risk in the community: a systematic review","volume":"3","author":"Curtis","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-014-0039-z","article-title":"Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol","volume":"13","author":"Abdulamir","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cis.2017.05.014_bb0290","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1038\/ncomms14187","article-title":"A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models","volume":"8","author":"Yen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cis.2017.05.014_bb0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AEM.00785-09","article-title":"Phage therapy to reduce preprocessing Salmonella infections in market-weight swine","volume":"76","author":"Wall","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fm.2013.08.018","article-title":"Effectiveness of a bacteriophage in reducing Listeria monocytogenes on fresh-cut fruits and fruit juices","volume":"38","author":"Oliveira","year":"2014","journal-title":"Food Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0305","first-page":"10","article-title":"Phage therapy: promising for H. pylori infection","volume":"2","author":"Hua Zou","year":"2013","journal-title":"Clin Microbiol Open Access"},{"key":"10.1016\/j.cis.2017.05.014_bb0310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2017.05.014_bb0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jtbi.2000.2198","article-title":"Understanding bacteriophage therapy as a density-dependent kinetic process","volume":"208","author":"Payne","year":"2001","journal-title":"J Theor Biol"},{"key":"10.1016\/j.cis.2017.05.014_bb0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1263\/jbb.100.280","article-title":"Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice","volume":"100","author":"Tanji","year":"2005","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.cis.2017.05.014_bb0325","first-page":"57927","article-title":"Synergistic elimination of bacteria by phage and the immune system","author":"Leung","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.cis.2017.05.014_bb0330","first-page":"307","article-title":"Successful Treatment of Experimental Escherichia coli Infections in Mice Using Phage: its General Superiority over Antibiotics","volume":"128","author":"Smith","year":"1982","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0335","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.cis.2017.05.014_bb0340","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/IAI.70.11.6251-6262.2002","article-title":"Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice","volume":"70","author":"Cerveny","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.cis.2017.05.014_bb0345","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CDLI.5.3.294-298.1998","article-title":"Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves","volume":"5","author":"Barrow","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cis.2017.05.014_bb0350","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.00635-06","article-title":"Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice","volume":"51","author":"Watanabe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/374001","article-title":"Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11","volume":"187","author":"Matsuzaki","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vetmic.2013.11.001","article-title":"Hurdles in bacteriophage therapy: Deconstructing the parameters","volume":"171","author":"Tsonos","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0365","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vetmic.2005.06.002","article-title":"Phage therapy reduces Campylobacter jejuni colonization in broilers","volume":"109","author":"Wagenaar","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0370","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ps\/86.9.1904","article-title":"Ability of bacteriophages isolated from different sources to reduce Salmonella enterica serovar enteritidis in vitro and in vivo","volume":"86","author":"Andreatti Filho","year":"2007","journal-title":"Poult Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0375","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4315\/0362-028X-73.7.1304","article-title":"Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157:H7 in feedlot cattle","volume":"73","author":"Stanford","year":"2010","journal-title":"J Food Prot"},{"key":"10.1016\/j.cis.2017.05.014_bb0380","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo","volume":"60","author":"Nale","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0385","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/AEM.00812-15","article-title":"Liposome-encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp.","volume":"81","author":"Colom","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0390","doi-asserted-by":"crossref","first-page":"41441","DOI":"10.1038\/srep41441","article-title":"Microencapsulation with alginate\/CaCO3: a strategy for improved phage therapy","volume":"7","author":"Colom","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2017.05.014_bb0395","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/fpd.2010.0621","article-title":"Development of an Anti-Salmonella Phage Cocktail with Increased Host Range","volume":"7","author":"Zhang","year":"2010","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0400","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1128\/AEM.01257-12","article-title":"Significance of the bacteriophage treatment schedule in reducing salmonella colonization of poultry","volume":"78","author":"Bardina","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0405","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biotechadv.2009.05.003","article-title":"Advances in on-line monitoring and control of mammalian cell cultures: supporting the PAT initiative","volume":"27","author":"Teixeira","year":"2009","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cis.2017.05.014_bb0410","series-title":"US 2009\/0130196 A1: bacteriophage composition","author":"Murthy","year":"2009"},{"key":"10.1016\/j.cis.2017.05.014_bb0415","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/AAC.48.7.2558-2569.2004","article-title":"In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy","volume":"48","author":"Chibani-Chennoufi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0420","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1085\/jgp.23.5.643","article-title":"The growth of bacteriophage and lysis of the host","volume":"23","author":"Delbruck","year":"1940","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/bact.1.1.13980","article-title":"Lysis from without","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.cis.2017.05.014_bb0430","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2009.03.009","article-title":"T4 phages against Escherichia coli diarrhea: potential and problems","volume":"388","author":"Denou","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cis.2017.05.014_bb0435","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.7717\/peerj.590","article-title":"Synergy as a rationale for phage therapy using phage cocktails","volume":"2","author":"Schmerer","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.cis.2017.05.014_bb0440","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev-virology-100114-054915","article-title":"Bacteriophage therapy: advances in forumulation strategies and human clinical trials","volume":"2","author":"Vandenheuvel","year":"2015","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.cis.2017.05.014_bb0445","first-page":"553","article-title":"Immunogenic effect of bactriophage in patients subjected to phage therapy","volume":"35","author":"Kucharewicz-Krukowska","year":"1987","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.cis.2017.05.014_bb0450","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ps\/81.10.1486","article-title":"Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray","volume":"81","author":"Huff","year":"2002","journal-title":"Poult Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0455","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1128\/AAC.02388-13","article-title":"Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections","volume":"58","author":"Semler","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cis.2017.05.014_bb0460","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3382\/ps.2008-00378","article-title":"The influence of the mode of administration in the dissemination of three coliphages in chickens","volume":"88","author":"Oliveira","year":"2009","journal-title":"Poult Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0465","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/cmi.12466","article-title":"Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes","volume":"17","author":"Cano","year":"2015","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0470","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/iai.65.11.4445-4451.1997","article-title":"N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells","volume":"65","author":"Fumagalli","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.cis.2017.05.014_bb0475","doi-asserted-by":"crossref","first-page":"e0153777","DOI":"10.1371\/journal.pone.0153777","article-title":"Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies","volume":"11","author":"Singla","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0480","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.12968\/jowc.2016.25.7.S27","article-title":"Bacteriophage treatment of intransigent diabetic toe ulcers: a case series","volume":"25","author":"Fish","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/j.cis.2017.05.014_bb0485","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.cis.2017.05.014_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0004944","article-title":"Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials","volume":"4","author":"Merabishvili","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0495","first-page":"66","article-title":"Experimental phage therapy of burn wound infection: difficult first steps","volume":"4","author":"Rose","year":"2014","journal-title":"Int J Burn Trauma"},{"key":"10.1016\/j.cis.2017.05.014_bb0500","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2008.12.001","article-title":"A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres","volume":"72","author":"Puapermpoonsiri","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0505","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/nl034911t","article-title":"Virus-based fabrication of micro- and nanofibers using electrospinning","volume":"4","author":"Lee","year":"2004","journal-title":"Nano Lett"},{"key":"10.1016\/j.cis.2017.05.014_bb0510","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2008.07.102","article-title":"The structural peptidoglycan hydrolase gp181 of bacteriophage phiKZ","volume":"374","author":"Briers","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cis.2017.05.014_bb0515","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2672.2011.05043.x","article-title":"Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation","volume":"111","author":"Knezevic","year":"2011","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0520","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s11095-016-1892-6","article-title":"Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections","volume":"33","author":"Leung","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2017.05.014_bb0525","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cryobiol.2013.03.007","article-title":"Effect of buffer systems and disaccharides concentration on Podoviridae coliphage stability during freeze drying and storage","volume":"66","author":"Dini","year":"2013","journal-title":"Cryobiology"},{"key":"10.1016\/j.cis.2017.05.014_bb0530","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jam.12158","article-title":"Incorporation of T4 bacteriophage in electrospun fibres","volume":"114","author":"Korehei","year":"2013","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0535","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/am.10.5.466-471.1962","article-title":"Comparison of several methods for preserving bacteriophages","volume":"10","author":"Clark","year":"1962","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0540","first-page":"573","article-title":"The preservation of bacteriophage H1 of Corynebacterium ulcerans U103 by freeze-drying","volume":"67","author":"Davies","year":"1969","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.cis.2017.05.014_bb0545","first-page":"35","article-title":"Long-term bacteriophage preservation","volume":"38","author":"Ackermann","year":"2004","journal-title":"WFCC Newsl"},{"key":"10.1016\/j.cis.2017.05.014_bb0550","series-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"vol. 203","author":"Wang","year":"2000"},{"key":"10.1016\/j.cis.2017.05.014_bb0555","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0560","first-page":"1209","article-title":"Dry powder inhaler formulation","volume":"50","author":"Telko","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.cis.2017.05.014_bb0565","first-page":"561","article-title":"The preservation of mycobacteriophages by means of freeze drying","volume":"109","author":"Engel","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0068797","article-title":"Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)","volume":"8","author":"Merabishvili","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cis.2017.05.014_bb0575","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/jam.12654","article-title":"The influence of stabilizers and rates of freezing on preserving of structurally different animal viruses during lyophilization and subsequent storage","volume":"117","author":"Malenovsk\u00e1","year":"2014","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2672.2010.04863.x","article-title":"In vitro lung delivery of bacteriophages KS4-M and \u03c6KZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis","volume":"110","author":"Golshahi","year":"2010","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0585","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2010.01.034","article-title":"Stabilization of bacteriophage during freeze drying","volume":"389","author":"Puapermpoonsiri","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0590","doi-asserted-by":"crossref","first-page":"225101","DOI":"10.1088\/0957-4484\/25\/22\/225101","article-title":"Electrospun water-soluble polymer nanofibers for the dehydration and storage of sensitive reagents","volume":"25","author":"Dai","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.cis.2017.05.014_bb0595","first-page":"207","article-title":"Viability and electron microscope studies of phages T3 and T7 subjected to freeze-drying, freeze-thawing and aerosolization","volume":"81","author":"Cox","year":"1974","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2017.01.060","article-title":"Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders","author":"Leung","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0605","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","article-title":"A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds","volume":"41","author":"Markoishvili","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cis.2017.05.014_bb0610","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mabi.201200109","article-title":"Novel biopolymer matrices for microencapsulation of phages: enhanced protection against acidity and protease activity","volume":"12","author":"Dini","year":"2012","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.cis.2017.05.014_bb0615","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2011.07.006","article-title":"Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation","volume":"416","author":"Alfadhel","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0620","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11095-013-1174-5","article-title":"Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery","volume":"31","author":"Hoe","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2017.05.014_bb0625","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/089426802760292672","article-title":"The role of particle properties in pharmaceutical powder inhalation formulations","volume":"15","author":"Chew","year":"2002","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.cis.2017.05.014_bb0630","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2009.05.008","article-title":"Insulin-micro- and nanoparticles for pulmonary delivery","volume":"377","author":"Klingler","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0635","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2014.08.013","article-title":"Inhaled antimicrobial therapy - barriers to effective treatment","volume":"85","author":"Weers","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0640","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2012.12.022","article-title":"Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections","volume":"84","author":"Vandenheuvel","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0645","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","article-title":"The influence of external factors on bacteriophages\u2014review","volume":"56","author":"Jo\u0144czyk","year":"2011","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.cis.2017.05.014_bb0650","series-title":"US20138501453B2: methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use","author":"Walbeck","year":"2013"},{"key":"10.1016\/j.cis.2017.05.014_bb0655","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1002\/jps.22715","article-title":"Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections","volume":"100","author":"Matinkhoo","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0660","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2014.06.026","article-title":"Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix","volume":"472","author":"Vandenheuvel","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0665","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0006-3495(96)79407-9","article-title":"Is trehalose special for preserving dry biomaterials?","volume":"71","author":"Crowe","year":"1996","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2017.05.014_bb0670","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijpharm.2003.10.039","article-title":"Alternative sugars as potential carriers for dry powder inhalations","volume":"270","author":"Steckel","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0675","series-title":"Methods for drying bacteriophage and bacteriophage containing compositions, the resulting dry compositions, and methods of use","article-title":"US 2009\/0093041 A1","author":"Walbeck","year":"2009"},{"key":"10.1016\/j.cis.2017.05.014_bb0680","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.0611430104","article-title":"Drying a tuberculosis vaccine without freezing","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cis.2017.05.014_bb0685","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/jamp.2014.1172","article-title":"Bacteriophage delivery by nebulization and efficacy against phenotypically diverse Pseudomonas aeruginosa from cystic fibrosis patients","volume":"28","author":"Sahota","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb0690","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jamp.2008.0701","article-title":"Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex","volume":"21","author":"Golshahi","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb0695","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/am.1.5.250-251.1953","article-title":"Storage of the bacteriophage of the lactic acid streptococci in the desiccated state with observations on longevity","volume":"1","author":"Prouty","year":"1953","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0700","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s11095-008-9580-9","article-title":"Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems","volume":"25","author":"Ibekwe","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2017.05.014_bb0705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","article-title":"Gut instincts: explorations in intestinal physiology and drug delivery","volume":"364","author":"McConnell","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0710","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/btpr.1898","article-title":"Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions","volume":"30","author":"Esteban","year":"2014","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.cis.2017.05.014_bb0715","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AEM.00246-08","article-title":"Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery","volume":"74","author":"Ma","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jfpe.12481","article-title":"Application of multicriteria decision technique to determine optimum sodium alginate concentration for microencapsulation of Lactobacillus casei Shirota by extrusion and emulsification","volume":"40","author":"Gul","year":"2017","journal-title":"J Food Process Eng"},{"key":"10.1016\/j.cis.2017.05.014_bb0725","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.foodhyd.2010.11.017","article-title":"Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage","volume":"26","author":"Ma","year":"2012","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.cis.2017.05.014_bb0730","doi-asserted-by":"crossref","first-page":"680108","DOI":"10.1100\/2012\/680108","article-title":"Preparation and characterization of alginate and psyllium beads containing Lactobacillus acidophilus","volume":"2012","author":"Lotfipour","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.cis.2017.05.014_bb0735","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejpb.2015.09.013","article-title":"Poly (N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K","volume":"96","author":"Hathaway","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0740","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1021\/cm503974g","article-title":"Triggered release of bacteriophage K from agarose\/hyaluronan hydrogel matrixes by Staphylococcus aureus virulence factors","volume":"26","author":"Bean","year":"2014","journal-title":"Chem Mater"},{"key":"10.1016\/j.cis.2017.05.014_bb0745","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.lwt.2015.12.039","article-title":"Carrier systems for bacteriophages to supplement food systems: encapsulation and controlled release to modulate the human gut microbiota","volume":"68","author":"Samtlebe","year":"2016","journal-title":"LWT- Food Sci Technol"},{"key":"10.1016\/j.cis.2017.05.014_bb0750","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/17425247.2015.1043125","article-title":"A first step toward liposome-mediated intracellular bacteriophage therapy","volume":"12","author":"Nieth","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb0755","series-title":"Encapsulation of bacteria and viruses in electrospun fibers","article-title":"US 2009\/0061496A1","author":"Kuhn","year":"2009"},{"key":"10.1016\/j.cis.2017.05.014_bb0760","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1088\/0957-4484\/17\/18\/025","article-title":"Encapsulation of bacteria and viruses in electrospun nanofibres","volume":"17","author":"Salalha","year":"2006","journal-title":"Nanotechnology"},{"key":"10.1016\/j.cis.2017.05.014_bb0765","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.carbpol.2013.03.079","article-title":"Encapsulation of T4 bacteriophage in electrospun poly(ethylene oxide)\/cellulose diacetate fibers","volume":"100","author":"Korehei","year":"2014","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cis.2017.05.014_bb0770","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.foodhyd.2013.09.017","article-title":"Encapsulation of bacteriophages in whey protein films for extended storage and release","volume":"37","author":"Vonasek","year":"2014","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.cis.2017.05.014_bb0775","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijfoodmicro.2015.10.011","article-title":"Development of prototypes of bioactive packaging materials based on immobilized bacteriophages for control of growth of bacterial pathogens in foods","volume":"217","author":"Lone","year":"2016","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0780","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3382\/ps\/pew255","article-title":"Evaluation of the efficacy of chitosan nanoparticles loaded FKAZ14 bacteriophage in the biological control of colibacillosis in chickens","volume":"96","author":"Kaikabo","year":"2017","journal-title":"Poult Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0785","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.foodres.2012.12.037","article-title":"Whey protein improves survival and release characteristics of bacteriophage Felix O1 encapsulated in alginate microspheres","volume":"52","author":"Tang","year":"2013","journal-title":"Food Res Int"},{"key":"10.1016\/j.cis.2017.05.014_bb0790","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/ijfs.12736","article-title":"Application of chitosan\u2013alginate microspheres for the sustained release of bacteriophage in simulated gastrointestinal conditions","volume":"50","author":"Kim","year":"2015","journal-title":"Int J Food Sci Technol"},{"key":"10.1016\/j.cis.2017.05.014_bb0795","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.lwt.2014.08.012","article-title":"Preparation and characterization of dry powder bacteriophage K for intestinal delivery through oral administration","volume":"60","author":"Tang","year":"2015","journal-title":"LWT- Food Sci Technol"},{"key":"10.1016\/j.cis.2017.05.014_bb0800","series-title":"US6703040B2: polymer blends as boidegradable matrices for preparing biocomposites","author":"Katsarava","year":"2004"},{"key":"10.1016\/j.cis.2017.05.014_bb0805","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/jphp.12389","article-title":"A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions","volume":"67","author":"Govender","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cis.2017.05.014_bb0810","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E","article-title":"Amino Acid-Based Bioanalogous Polymers. Synthesis, and Study of Regular Poly(ester amide)s Based on Bis(alpha-amino acid) alpha,omega-Alkylene Diesters, and Aliphatic Dicarboxylic Acids","volume":"37","author":"Katsarava","year":"1999","journal-title":"J Polym Sci: Part A: Polym Chem"},{"key":"10.1016\/j.cis.2017.05.014_bb0815","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.cis.2017.05.014_bb0820","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1211\/0022357011775163","article-title":"Gastrointestinal transit of dosage forms in the pig","volume":"53","author":"Davis","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cis.2017.05.014_bb0825","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fm.2015.05.007","article-title":"Use of the dynamic gastro-intestinal model TIM to explore the survival of the yogurt bacterium Streptococcus thermophilus and the metabolic activities induced in the simulated human gut","volume":"53","author":"Uriot","year":"2016","journal-title":"Food Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb0830","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5001\/omj.2010.24","article-title":"Colon targeted drug delivery systems: a review on primary and novel approaches","volume":"25","author":"Philip","year":"2010","journal-title":"Oman Med J"},{"key":"10.1016\/j.cis.2017.05.014_bb0835","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biotechadv.2014.07.006","article-title":"A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules","volume":"32","author":"Choonara","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cis.2017.05.014_bb0840","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","article-title":"Colon-targeted oral drug delivery systems: design trends and approaches","volume":"16","author":"Amidon","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.cis.2017.05.014_bb0845","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11894-006-0021-9","article-title":"Ileal brake: neuropeptidergic control of intestinal transit","volume":"8","author":"Van Citters","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cis.2017.05.014_bb0850","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.cis.2017.05.014_bb0855","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cis.2017.05.014_bb0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI110737","article-title":"Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit","volume":"71","author":"Inman","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cis.2017.05.014_bb0865","first-page":"277","article-title":"Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells","volume":"73","author":"Pappo","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.cis.2017.05.014_bb0870","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/17425247.1.1.141","article-title":"Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery","volume":"1","author":"Shakweh","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review","volume":"114","author":"George","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2017.05.014_bb0880","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0885","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0890","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1208\/pt060116","article-title":"Eudragit S100 entrapped insulin microspheres for oral delivery","volume":"6","author":"Jain","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.cis.2017.05.014_bb0895","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2006.06.008","article-title":"Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation","volume":"29","author":"Silva","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0900","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2010.06.013","article-title":"Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis","volume":"76","author":"Kietzmann","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0905","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2478\/v10007-012-0034-x","article-title":"Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation","volume":"62","author":"Chawla","year":"2012","journal-title":"Acta Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0910","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.msec.2014.02.003","article-title":"Novel Pullulan-Eudragit S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles","volume":"38","author":"De Arce","year":"2014","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.cis.2017.05.014_bb0915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nmat2614","article-title":"Emerging applications of stimuli-responsive polymer materials","volume":"9","author":"Stuart","year":"2010","journal-title":"Nat Mater"},{"key":"10.1016\/j.cis.2017.05.014_bb0920","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","article-title":"Drug delivery strategies in the therapy of inflammatory bowel disease","volume":"71","author":"Lautenschl\u00e4ger","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0925","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S1984-82502013000300014","article-title":"Development of enteric coated sustained release minitablets containing mesalamine","volume":"49","author":"de Souza","year":"2013","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0930","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0935","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-Gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cis.2017.05.014_bb0940","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ps\/86.2.309","article-title":"Evaluation of the efficacy of a probiotic containing Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities","volume":"86","author":"Mountzouris","year":"2007","journal-title":"Poult Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0945","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v13.i3-4.10","article-title":"Current applications of polysaccharides in colon targeting","volume":"13","author":"Hovgaard","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.cis.2017.05.014_bb0950","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0144-8617(01)00263-6","article-title":"The use of polysaccharides to target drugs to the colon","volume":"48","author":"Vandamme","year":"2002","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cis.2017.05.014_bb0955","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-3659(97)00203-4","article-title":"Design of microencapsulated chitosan microspheres for colonic drug delivery","volume":"52","author":"Lorenzo-Lamosa","year":"1998","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2017.05.014_bb0960","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpb.2008.06.006","article-title":"Carboxymethyl high amylose starch: chitosan self-stabilized matrix for probiotic colon delivery","volume":"70","author":"Calinescu","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0965","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-5173(98)00017-9","article-title":"Basic studies on bioadhesive delivery systems for peptide and protein drugs","volume":"165","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0970","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-409X(01)00180-6","article-title":"Chitosan and its derivatives as intestinal absorption enhancers","volume":"50","author":"Thanou","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb0975","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","article-title":"Chitosan and its derivatives in mucosal drug and vaccine delivery","volume":"14","author":"Van der Lubben","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb0980","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jbiotec.2006.04.030","article-title":"Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination","volume":"126","author":"Lameiro","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1016\/j.cis.2017.05.014_bb0985","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2005.06.028","article-title":"Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs","volume":"303","author":"Takeuchi","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb0990","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.10.023","article-title":"Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes","volume":"125","author":"Thirawong","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2017.05.014_bb0995","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jfoodeng.2013.02.012","article-title":"Encapsulation of probiotic Lactobacillus bulgaricus in alginate\u2013milk microspheres and evaluation of the survival in simulated gastrointestinal conditions","volume":"117","author":"Shi","year":"2013","journal-title":"J Food Eng"},{"key":"10.1016\/j.cis.2017.05.014_bb1000","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bioeng.2007.02.002","article-title":"A simple two-transition model for loss of infectivity of phages on exposure to organic solvent","volume":"24","author":"Matsubara","year":"2007","journal-title":"Biomol Eng"},{"key":"10.1016\/j.cis.2017.05.014_bb1005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-5521(01)00041-2","article-title":"Filamentous bacteriophage stability in non-aqueous media","volume":"8","author":"Olofsson","year":"2001","journal-title":"Chem Biol"},{"key":"10.1016\/j.cis.2017.05.014_bb1010","series-title":"US7601347 B2: methods and compositions for controlled release of bioactive compounds","author":"Waddell","year":"2009"},{"key":"10.1016\/j.cis.2017.05.014_bb1015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bios.2016.02.059","article-title":"An in-situ infection detection sensor coating for urinary catheters","volume":"81","author":"Milo","year":"2016","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.cis.2017.05.014_bb1020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bpj.2013.05.024","article-title":"Gel-assisted formation of giant unilamellar vesicles","volume":"105","author":"Weinberger","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2017.05.014_bb1025","doi-asserted-by":"crossref","first-page":"10718","DOI":"10.1073\/pnas.1931005100","article-title":"Engineering asymmetric vesicles","volume":"100","author":"Pautot","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1030","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.colsurfb.2014.09.045","article-title":"Biomimetic aqueous-core lipid nanoballoons integrating a multiple emulsion formulation: a suitable housing system for viable lytic bacteriophages","volume":"123","author":"Balcao","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2017.05.014_bb1035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cis.2017.05.014_bb1040","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.cis.2017.05.014_bb1045","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3748\/wjg.v18.i23.2895","article-title":"Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases","volume":"18","author":"Pichai","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cis.2017.05.014_bb1050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2012.10.019","article-title":"Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa - a first in vivo study in human patients","volume":"165","author":"Schmidt","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2017.05.014_bb1055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.07.017","article-title":"Drug delivery to inflamed colon by nanoparticles: comparison of different strategies","volume":"440","author":"Coco","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb1060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nmat2347","article-title":"Stealth particles give mucus the slip","volume":"8","author":"Cu","year":"2009","journal-title":"Nat Mater"},{"key":"10.1016\/j.cis.2017.05.014_bb1065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2017.05.014_bb1070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","article-title":"Antibody diffusion in human cervical mucus","volume":"66","author":"Saltzman","year":"1994","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2017.05.014_bb1075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(99)00061-7","article-title":"Tuftsin-bearing liposomes in treatment of macrophage-based infections","volume":"41","author":"Agrawal","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2017.05.014_bb1080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/343812","article-title":"Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium: a model for phage therapy of intracellular bacterial pathogens","volume":"186","author":"Broxmeyer","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cis.2017.05.014_bb1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2006.12.1","article-title":"In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent Mycobacterium","volume":"12","author":"Danelishvili","year":"2006","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cis.2017.05.014_bb1090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/156720105774370177","article-title":"Targeted drug delivery to macrophages in parasitic infections","volume":"2","author":"Owais","year":"2005","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.cis.2017.05.014_bb1095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0041-3879(86)90002-4","article-title":"The use of rifampicin and isoniazid entrapped in liposomes for the treatment of murine tuberculosis","volume":"67","author":"Orozco","year":"1986","journal-title":"Tubercle"},{"key":"10.1016\/j.cis.2017.05.014_bb1100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s004230050010","article-title":"Acceleration of wound healing by topical drug delivery via liposomes","volume":"385","author":"Roesken","year":"2000","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.cis.2017.05.014_bb1105","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.reactfunctpolym.2013.05.012","article-title":"Functionalization of gauzes with liposomes entrapping an anti-inflammatory drug: a strategy to improve wound healing","volume":"73","author":"Ferreira","year":"2013","journal-title":"React Funct Polym"},{"key":"10.1016\/j.cis.2017.05.014_bb1110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/abbi.1994.1387","article-title":"Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing","volume":"313","author":"Yerushalmi","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cis.2017.05.014_bb1115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1021\/bm400290u","article-title":"Phage-bacterium war on polymeric surfaces: can surface-anchored bacteriophages eliminate microbial infections?","volume":"14","author":"Pearson","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cis.2017.05.014_bb1120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2672.1997.00257.x","article-title":"The use of bacteriophage-based systems for the separation and concentration of Salmonella","volume":"83","author":"Bennett","year":"1997","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb1125","first-page":"273","article-title":"Food-borne pathogens. Use of bioluminescent Salmonella for assessing the efficiency of constructed phage-based biosorbent y,z","author":"Sun","year":"2001","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb1130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AEM.02294-09","article-title":"Oriented immobilization of bacteriophages for biosensor applications","volume":"76","author":"Tolba","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb1135","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/AEM.05493-11","article-title":"Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes","volume":"77","author":"Anany","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.cis.2017.05.014_bb1140","series-title":"US9457132B2: controlled covalent attachment of bioactive bacteriophage for regulating biofilm development","author":"Donlan","year":"2016"},{"key":"10.1016\/j.cis.2017.05.014_bb1145","series-title":"WO2003093462A2: immobilisation and stabilisation of virus","author":"Scott","year":"2003"},{"key":"10.1016\/j.cis.2017.05.014_bb1150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mimet.2015.02.005","article-title":"Bacteriophage-nanocomposites: an easy and reproducible method for the construction, handling, storage and transport of conjugates for deployment of bacteriophages active against Pseudomonas aeruginosa","volume":"111","author":"Cooper","year":"2015","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.cis.2017.05.014_bb1155","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.susc.2008.01.036","article-title":"Recognition of Salmonella typhimurium by immobilized phage P22 monolayers","volume":"602","author":"Handa","year":"2008","journal-title":"Surf Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1160","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.bios.2009.05.028","article-title":"Immobilization of bacteriophages on gold surfaces for the specific capture of pathogens","volume":"24","author":"Singh","year":"2009","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.cis.2017.05.014_bb1165","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1021\/ac052287u","article-title":"Virus electrodes for universal biodetection","volume":"78","author":"Yang","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.cis.2017.05.014_bb1170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.snb.2015.09.042","article-title":"Ordering of bacteriophages in the electric field: application for bacteria detection","volume":"224","author":"Richter","year":"2016","journal-title":"Sens Actuators B"},{"key":"10.1016\/j.cis.2017.05.014_bb1175","doi-asserted-by":"crossref","first-page":"14375","DOI":"10.1021\/acs.jpcc.5b02169","article-title":"Surface chemistry of bacteriophage and laser ablated nanoparticle complexes for pathogen detection","volume":"119","author":"Tawil","year":"2015","journal-title":"J Phys Chem C"},{"key":"10.1016\/j.cis.2017.05.014_bb1180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2004.10.002","article-title":"Recent developments in manufacturing emulsions and particulate products using membranes","volume":"113","author":"Vladisavljevic","year":"2005","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.memsci.2008.11.026","article-title":"Shirasu porous glass (SPG) membrane emulsification in the absence of shear flow at the membrane surface: influence of surfactant type and concentration, viscosities of dispersed and continuous phases, and transmembrane pressure","volume":"327","author":"Kukizaki","year":"2009","journal-title":"J Membr Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10404-012-0948-0","article-title":"Production of uniform droplets using membrane, microchannel and microfluidic emulsification devices","volume":"13","author":"Vladisavljevi\u0107","year":"2012","journal-title":"Microfluid Nanofluid"},{"key":"10.1016\/j.cis.2017.05.014_bb1195","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1021\/ie0504699","article-title":"Liquid-liquid membrane dispersion in a stirred cell with and without controlled shear","volume":"44","author":"Kosvintsev","year":"2005","journal-title":"Ind Eng Chem Res"},{"key":"10.1016\/j.cis.2017.05.014_bb1200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcis.2006.01.061","article-title":"Manufacture of large uniform droplets using rotating membrane emulsification","volume":"299","author":"Vladisavljevi\u0107","year":"2006","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1205","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1021\/ie900531n","article-title":"Membrane emulsification with oscillating and stationary membranes","volume":"49","author":"Holdich","year":"2010","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.cis.2017.05.014_bb1210","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/aic.14894","article-title":"Azimuthally oscillating membrane emulsification for controlled droplet production","volume":"61","author":"Silva","year":"2015","journal-title":"AIChE J"},{"key":"10.1016\/j.cis.2017.05.014_bb1215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-fluid-122414-034425","article-title":"Droplets and bubbles in microfluidic devices","volume":"48","author":"Anna","year":"2016","journal-title":"Annu Rev Fluid Mech"},{"key":"10.1016\/j.cis.2017.05.014_bb1220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cocis.2007.09.003","article-title":"Controlled production of emulsions and particles by milli- and microfluidic techniques","volume":"13","author":"Engl","year":"2008","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.cis.2017.05.014_bb1225","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1039\/b602240e","article-title":"High-performance flow-focusing geometry for spontaneous generation of monodispersed droplets","volume":"6","author":"Yobas","year":"2006","journal-title":"Lab Chip"},{"key":"10.1016\/j.cis.2017.05.014_bb1230","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1002\/anie.200701358","article-title":"Controllable monodisperse multiple emulsions","volume":"46","author":"Chu","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2017.05.014_bb1235","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1039\/c1lc20065h","article-title":"Controllable microfluidic production of multicomponent multiple emulsions","volume":"11","author":"Wang","year":"2011","journal-title":"Lab Chip"},{"key":"10.1016\/j.cis.2017.05.014_bb1240","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/smll.200900569","article-title":"High-order multiple emulsions formed in poly(dimethylsiloxane) microfluidics","volume":"5","author":"Abate","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.cis.2017.05.014_bb1245","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1002\/anie.201102946","article-title":"One-step emulsification of multiple concentric shells with capillary microfluidic devices","volume":"50","author":"Kim","year":"2011","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2017.05.014_bb1250","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1039\/c2lc90046g","article-title":"Microfluidic synthesis of multifunctional Janus particles for biomedical applications","volume":"12","author":"Yang","year":"2012","journal-title":"Lab Chip"},{"key":"10.1016\/j.cis.2017.05.014_bb1255","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1021\/ja060882n","article-title":"Janus and ternary particles generated by microfluidic synthesis: design, synthesis, and self-assembly","volume":"128","author":"Nie","year":"2006","journal-title":"J Am Chem Soc"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000186861630392X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000186861630392X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T23:46:24Z","timestamp":1706226384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000186861630392X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":251,"alternative-id":["S000186861630392X"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2017.05.014","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}